Medically supervised weight loss with advanced GLP-1 medications. Achieve 12–22% body weight reduction with Semaglutide and Tirzepatide under expert guidance.
GLP-1 Programs
GLP-1 medications for medically supervised weight loss.
The cutting-edge triple agonist representing the next generation of weight loss medication. GLP-1, GIP, and Glucagon receptor activity.
Mechanism
Weight Loss
GLP-1/GIP/Glucagon triple agonist
TBD
Dosing
Best For
Weekly injectable
Next-generation weight management
The most established GLP-1 medication with extensive clinical data. Ideal for starting your weight loss journey with proven cardiovascular benefits.
Mechanism
Weight Loss
GLP-1 + GIP dual agonist
~12–15%
Dosing
Best For
Weekly injectable / Daily oral
Broad use, strong data, CV benefit
The market leader for weight loss results. Dual-action mechanism delivers the highest weight loss percentages currently available — up to 22%.
Mechanism
Weight Loss
GLP-1 + GIP dual agonist
~18–22%
Dosing
Best For
Weekly injectable
Maximum weight loss, insulin resistance
Have Questions?
Find answers to common questions about our treatments, providers, locations, and more.
Join patients achieving real results with medically supervised GLP-1 weight loss. Get started or fast track your order now.